Mariana González-Medina1, Fernando D Prieto-Martínez1, J Jesús Naveja1, Oscar Méndez-Lucio1, Tamam El-Elimat2, Cedric J Pearce3, Nicholas H Oberlies4, Mario Figueroa1, José L Medina-Franco1. 1. Facultad de Química, Departamento de Farmacia, Universidad Nacional Autónoma de México, Avenida Universidad 3000, México City 04510, México. 2. Department of Medicinal Chemistry & Pharmacognosy, Faculty of Pharmacy, Jordan University of Science & Technology, PO Box 3030, Irbid 22110, Jordan. 3. Mycosynthetix, Inc., 505 Meadowland Drive, Suite 103, Hillsborough, NC 27278, USA. 4. Department of Chemistry & Biochemistry, University of North Carolina at Greensboro, PO Box 26170, Greensboro, NC 27402, USA.
Abstract
AIM: Fungi are valuable resources for bioactive secondary metabolites. However, the chemical space of fungal secondary metabolites has been studied only on a limited basis. Herein, we report a comprehensive chemoinformatic analysis of a unique set of 207 fungal metabolites isolated and characterized in a USA National Cancer Institute funded drug discovery project. RESULTS: Comparison of the molecular complexity of the 207 fungal metabolites with approved anticancer and nonanticancer drugs, compounds in clinical studies, general screening compounds and molecules Generally Recognized as Safe revealed that fungal metabolites have high degree of complexity. Molecular fingerprints showed that fungal metabolites are as structurally diverse as other natural products and have, in general, drug-like physicochemical properties. CONCLUSION: Fungal products represent promising candidates to expand the medicinally relevant chemical space. This work is a significant expansion of an analysis reported years ago for a smaller set of compounds (less than half of the ones included in the present work) from filamentous fungi using different structural properties.
AIM: Fungi are valuable resources for bioactive secondary metabolites. However, the chemical space of fungal secondary metabolites has been studied only on a limited basis. Herein, we report a comprehensive chemoinformatic analysis of a unique set of 207 fungal metabolites isolated and characterized in a USA National Cancer Institute funded drug discovery project. RESULTS: Comparison of the molecular complexity of the 207 fungal metabolites with approved anticancer and nonanticancer drugs, compounds in clinical studies, general screening compounds and molecules Generally Recognized as Safe revealed that fungal metabolites have high degree of complexity. Molecular fingerprints showed that fungal metabolites are as structurally diverse as other natural products and have, in general, drug-like physicochemical properties. CONCLUSION: Fungal products represent promising candidates to expand the medicinally relevant chemical space. This work is a significant expansion of an analysis reported years ago for a smaller set of compounds (less than half of the ones included in the present work) from filamentous fungi using different structural properties.
Authors: Tamam El-Elimat; Xiaoli Zhang; David Jarjoura; Franklin J Moy; Jimmy Orjala; A Douglas Kinghorn; Cedric J Pearce; Nicholas H Oberlies Journal: ACS Med Chem Lett Date: 2012-07-12 Impact factor: 4.345
Authors: Sloan Ayers; Tyler N Graf; Audrey F Adcock; David J Kroll; Qi Shen; Steven M Swanson; Mansukh C Wani; Blaise A Darveaux; Cedric J Pearce; Nicholas H Oberlies Journal: Tetrahedron Lett Date: 2011-10-05 Impact factor: 2.415
Authors: Sloan Ayers; Brandie M Ehrmann; Audrey F Adcock; David J Kroll; Esperanza J Carcache de Blanco; Qi Shen; Steven M Swanson; Joseph O Falkinham; Mansukh C Wani; Sheila M Mitchell; Cedric J Pearce; Nicholas H Oberlies Journal: J Pept Sci Date: 2012-06-29 Impact factor: 1.905
Authors: Tatiana Okouneva; Olga Azarenko; Leslie Wilson; Bruce A Littlefield; Mary Ann Jordan Journal: Mol Cancer Ther Date: 2008-07 Impact factor: 6.261
Authors: Narender Singh; Rajarshi Guha; Marc A Giulianotti; Clemencia Pinilla; Richard A Houghten; Jose L Medina-Franco Journal: J Chem Inf Model Date: 2009-04 Impact factor: 4.956
Authors: Sloan Ayers; Tyler N Graf; Audrey F Adcock; David J Kroll; Qi Shen; Steven M Swanson; Susan Matthew; Esperanza J Carcache de Blanco; Mansukh C Wani; Blaise A Darveaux; Cedric J Pearce; Nicholas H Oberlies Journal: J Antibiot (Tokyo) Date: 2011-11-09 Impact factor: 2.649
Authors: Noemi D Paguigan; Mohammed H Al-Huniti; Huzefa A Raja; Austin Czarnecki; Joanna E Burdette; Mariana González-Medina; José L Medina-Franco; Stephen J Polyak; Cedric J Pearce; Mitchell P Croatt; Nicholas H Oberlies Journal: Bioorg Med Chem Date: 2017-07-28 Impact factor: 3.641
Authors: Leslie N Aldrich; Joanna E Burdette; Esperanza Carcache de Blanco; Christopher C Coss; Alessandra S Eustaquio; James R Fuchs; A Douglas Kinghorn; Amanda MacFarlane; Brittney K Mize; Nicholas H Oberlies; Jimmy Orjala; Cedric J Pearce; Mitch A Phelps; Liva Harinantenaina Rakotondraibe; Yulin Ren; Djaja Doel Soejarto; Brent R Stockwell; Jack C Yalowich; Xiaoli Zhang Journal: J Nat Prod Date: 2022-02-25 Impact factor: 4.803
Authors: Sonja L Knowles; Christopher D Roberts; Mario Augustinović; Laura Flores-Bocanegra; Huzefa A Raja; Kimberly N Heath-Borrero; Joanna E Burdette; Joseph O Falkinham Iii; Cedric J Pearce; Nicholas H Oberlies Journal: J Nat Prod Date: 2021-03-25 Impact factor: 4.050
Authors: Mariana González-Medina; Fernando D Prieto-Martínez; John R Owen; José L Medina-Franco Journal: J Cheminform Date: 2016-11-10 Impact factor: 5.514
Authors: José Rivera-Chávez; Huzefa A Raja; Tyler N Graf; Joanna E Burdette; Cedric J Pearce; Nicholas H Oberlies Journal: J Nat Prod Date: 2017-06-08 Impact factor: 4.050
Authors: Mariana González-Medina; John R Owen; Tamam El-Elimat; Cedric J Pearce; Nicholas H Oberlies; Mario Figueroa; José L Medina-Franco Journal: Front Pharmacol Date: 2017-04-03 Impact factor: 5.810
Authors: Laura Flores-Bocanegra; Huzefa A Raja; Jeffrey W Bacon; Amanda C Maldonado; Joanna E Burdette; Cedric J Pearce; Nicholas H Oberlies Journal: J Nat Prod Date: 2020-10-02 Impact factor: 4.050
Authors: Zeinab Y Al Subeh; Huzefa A Raja; Joanna E Burdette; Joseph O Falkinham; Scott E Hemby; Nicholas H Oberlies Journal: Phytochemistry Date: 2021-06-20 Impact factor: 4.004